CCK, schizophrenia, and anxiety. CCK-B antagonists inhibit the activity of brain dopamine neurons
- Ann N Y Acad Sci. 1994 Mar 23;713:300-11. doi: 10.1111/j.1749-6632.1994.tb44078.x.
Affiliations
- 1. Lilly Research Laboratories, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, Indiana 46285.
PMID: 8185172
DOI: 10.1111/j.1749-6632.1994.tb44078.x
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Cholecystokinin ReceptorResearch Areas: Neurological Disease